Apr 30, 2016
A beacon of opportunities, the Global Anti-Aging Market has demonstrated a humongous growth in a span of about two decades.
Feb 08, 2012
Findings from the report suggest that the total global spending on clinical is expected to grow at around 4% and that on biopharmaceutical products to grow robustly at 9%.
Feb 01, 2012
A number of smart card projects such as the UID, E-passports, EPFO, etc have been delayed or cancelled due to problems like lack of funds, technical issues, legal wrangling, etc.
Jan 25, 2012
Lantus is expected to be the most lucrative target for biosimilar manufacturers and account for 71% of the total biosimilar Insulin sales by 2020.
Jan 24, 2012
Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India
Jan 23, 2012
The penetration of smart cards in the Indian banking and retail industries are currently very low but offer immense opportunities for future growth.
Jan 19, 2012
The demand for efficient storage and transportation of clinical trial materials is expected to increase robustly in the coming years